...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis.
【24h】

PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis.

机译:PD-ECGF,bFGF和VEGF在非小细胞肺癌中的表达及其与淋巴结转移的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

The angiogenic factors PD-ECGF, bFGF and VEGF were determined immunohistochemically in 168 non-small cell lung carcinomas to investigate whether the expression of these parameters is correlated with lymph node metastasis of patients. The expressions of the above mentioned factors was indeed associated with lymph node metastasis, but the results were not statistically significant. However, a combination of the factors PD-ECGF, bFGF and VEGF significantly improved the prognostic information. The number of tumors with lymph node involvement increased with the number of angiogenic factors. Only 43% of the patients had-lymph node involvement when all factors were negative whereas 77% showed metastasis when all factors were positive (one factor positive: 53%, two factors positive: 68). This result is statistically significant (p = 0.002, test for trend).
机译:通过免疫组织化学方法在168例非小细胞肺癌中确定血管生成因子PD-ECGF,bFGF和VEGF,以研究这些参数的表达是否与患者淋巴结转移相关。上述因素的表达确实与淋巴结转移有关,但结果无统计学意义。但是,PD-ECGF,bFGF和VEGF因子的组合可显着改善预后信息。淋巴结受累的肿瘤数目随血管生成因子数目的增加而增加。当所有因素均为阴性时,只有43%的患者有淋巴结受累,而当所有因素均为阳性时,则有77%出现转移(一个因素阳性:53%,两个因素阳性:68)。该结果具有统计学意义(p = 0.002,趋势检验)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号